2m 2m 2m 2m 2m 2m 2m
PRECISIO BIO (DTIL)
NASDAQ
$6.77+$0.05 (+0.82%)
Price as of Oct 22, 2026 7:30 PM EDT- $185.2MMarket Cap
- -3.17%1-Year Change
- BiotechnologyIndustry
PRECISIO BIO (DTIL)
$6.77+$0.05 (+0.82%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
CVI HOLDINGS, LLC | 15.40% | 4.3M | +4.3M (+100.00%) | Jun 30, 2022 |
ABRDN PLC | 8.08% | 2.2M | 0 (0.00%) | Jun 30, 2026 |
BLEICHROEDER LP | 7.31% | 2.0M | +355,690 (+17.62%) | Jun 30, 2026 |
OCTAGON CAPITAL ADVISORS LP | 4.89% | 1.4M | -886,732 (-65.68%) | Jun 30, 2026 |
BOOTHBAY FUND MANAGEMENT, LLC | 4.88% | 1.3M | +279,954 (+20.80%) | Jun 30, 2026 |
BLACKROCK, INC. | 4.25% | 1.2M | +973,112 (+82.97%) | Jun 30, 2026 |
OUP MANAGEMENT CO., LLC | 4.07% | 1.1M | 0 (0.00%) | Sep 30, 2023 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
Tekla World Healthcare Fund | 4.15% | 1.1M | 0 (0.00%) | Jun 30, 2026 |
VANGUARD INDEX FUNDS | 3.95% | 1.1M | +196,223 (+17.99%) | Jun 30, 2026 |
TEKLA LIFE SCIENCES INVESTORS | 3.93% | 1.1M | 0 (0.00%) | Jun 30, 2026 |
MERIDIAN FUND INC | 0.99% | 274,140 | +95,000 (+34.65%) | Jun 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.95% | 261,845 | +228,279 (+87.18%) | Jul 31, 2026 |
SCHWAB CAPITAL TRUST | 0.28% | 78,327 | +58,327 (+74.47%) | Jul 31, 2026 |
CORNERCAP GROUP OF FUNDS /VA/ | 0.25% | 69,694 | +37,186 (+53.36%) | Sep 30, 2022 |
Current Ownership Distribution
- Institutions455.2M (64.98%)
- Mutual Funds223.1M (31.85%)
- Insiders22.3M (3.18%)
- Other0 (0.00%)
Insider Transactions
- 3.18% (22.3M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $529,458.41Amount of InsiderBuying (last 12 months)
- 4Number of InsiderSelling (last 12 months)
- $3.7MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Frankel Stanley | Buy | Sep 28, 2026 | $6,000.00 | 1,000 | $6.00 | 41,478 |
Amoroso Michael President and CEO | Sell | Feb 18, 2026 | $78,946.56 | 20,559 | $3.84 | 243,392 |
Kelly John Alexander Chief Financial Officer | Sell | Feb 18, 2026 | $31,292.16 | 8,149 | $3.84 | 125,883 |
SMITH J. JEFFERSON Chief Research Officer | Sell | Feb 18, 2026 | $18,912.00 | 4,925 | $3.84 | 121,926 |
Scimeca Dario General Counsel and Secretary | Sell | Feb 18, 2026 | $18,912.00 | 4,925 | $3.84 | 56,457 |
Kelly John Alexander Chief Financial Officer | Exempt | Feb 17, 2026 | $0.00 | 27,584 | $0.00 | 55,166 |
SMITH J. JEFFERSON Chief Research Officer | Exempt | Feb 17, 2026 | $0.00 | 16,667 | $0.00 | 33,333 |
Kelly John Alexander Chief Financial Officer | Exempt | Feb 17, 2026 | $0.00 | 27,584 | $0.00 | 134,032 |
Amoroso Michael President and CEO | Exempt | Feb 17, 2026 | $0.00 | 67,797 | $0.00 | 135,593 |
SMITH J. JEFFERSON Chief Research Officer | Exempt | Feb 17, 2026 | $0.00 | 16,667 | $0.00 | 126,851 |
Scimeca Dario General Counsel and Secretary | Exempt | Feb 17, 2026 | $0.00 | 16,667 | $0.00 | 33,333 |
Amoroso Michael President and CEO | Exempt | Feb 17, 2026 | $0.00 | 67,797 | $0.00 | 263,951 |
Scimeca Dario General Counsel and Secretary | Exempt | Feb 17, 2026 | $0.00 | 16,667 | $0.00 | 61,382 |
Amoroso Michael President and CEO | Sell | Jan 22, 2026 | $145,111.83 | 34,799 | $4.17 | 196,154 |
Scimeca Dario General Counsel and Secretary | Sell | Jan 21, 2026 | $35,681.62 | 8,854 | $4.03 | 44,715 |
Kelly John Alexander Chief Financial Officer | Sell | Jan 21, 2026 | $61,308.39 | 15,213 | $4.03 | 106,448 |
SMITH J. JEFFERSON Chief Research Officer | Exempt | Jan 21, 2026 | $0.00 | 16,219 | $0.00 | 120,384 |
SMITH J. JEFFERSON Chief Research Officer | Sell | Jan 21, 2026 | $41,106.00 | 10,200 | $4.03 | 110,184 |
Amoroso Michael President and CEO | Exempt | Jan 20, 2026 | $0.00 | 8,888 | $0.00 | 0 |
Scimeca Dario General Counsel and Secretary | Exempt | Jan 20, 2026 | $0.00 | 1,978 | $0.00 | 0 |
Kelly John Alexander Chief Financial Officer | Exempt | Jan 20, 2026 | $0.00 | 3,888 | $0.00 | 0 |
SMITH J. JEFFERSON Chief Research Officer | Exempt | Jan 20, 2026 | $0.00 | 2,500 | $0.00 | 0 |
Amoroso Michael President and CEO | Exempt | Jan 20, 2026 | $0.00 | 37,069 | $0.00 | 37,069 |
Scimeca Dario General Counsel and Secretary | Exempt | Jan 20, 2026 | $0.00 | 8,425 | $0.00 | 8,425 |
Kelly John Alexander Chief Financial Officer | Exempt | Jan 20, 2026 | $0.00 | 13,900 | $0.00 | 13,901 |
SMITH J. JEFFERSON Chief Research Officer | Exempt | Jan 20, 2026 | $0.00 | 10,447 | $0.00 | 10,447 |
Amoroso Michael President and CEO | Exempt | Jan 20, 2026 | $0.00 | 69,421 | $0.00 | 69,421 |
Scimeca Dario General Counsel and Secretary | Exempt | Jan 20, 2026 | $0.00 | 14,908 | $0.00 | 14,907 |
Kelly John Alexander Chief Financial Officer | Exempt | Jan 20, 2026 | $0.00 | 26,575 | $0.00 | 26,575 |
SMITH J. JEFFERSON Chief Research Officer | Exempt | Jan 20, 2026 | $0.00 | 16,219 | $0.00 | 16,219 |